In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans

Seven antimicrobials were tested in vitro against 29 clinical isolates of Mycobacterium ulcerans. R207910 demonstrated the lowest MIC(50) and MIC(90), followed by moxifloxacin (MXF), streptomycin (STR), rifampin (RIF), amikacin (AMK), linezolid (LZD), and PA-824. All but PA-824 demonstrated an MIC(9...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ji, Baohong, Lefrançois, Sébastien, Robert, Jerome, Chauffour, Aurélie, Truffot, Chantal, Jarlier, Vincent
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2006
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1479135/
https://ncbi.nlm.nih.gov/pubmed/16723546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00052-06
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars